ArticleWorld journal of gastroenterology2019

Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.

Won Hyeok Choe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.